Saavedra, Kristel Jane S.
HRN: 18-16-40 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/31/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
03/31/2026
04/01/2026
IV
900mg
Q8hrs
S/P CS
Checking Initial Appropriateness
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines